KRAS and hyperplastic polyposis syndrome: In serrated polyposis, Rosty et al. [11] reported 47.3% of CRCs had BRAF mutation while another 47.3% were BRAF/KRAS wild type, and 4/13 CRCs with contiguous residual polyp harbored conventional adenomas.